Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-2-2
|
pubmed:abstractText |
Natriuretic peptide receptor C (NPR-C) mRNA expression and ANP-binding activity via NPR-C are significantly down-regulated in HeLa cells with phorbol myristate acetate (PMA) treatment. Stabilization of the NPR-C mRNA by PMA indicated that down-regulation of its mRNA was mediated through negative transcriptional regulation. Despite the significant loss of the mRNA, reduction of NPR-C-specific ANP-binding activity after PMA exposure (4 h) was accompanied by a slight decrease in total NPR-C protein (with a 5% loss) and was also produced in the presence of actinomycin D or cycloheximide. The inhibitory effect of a long PMA exposure (18 h) paralleled with a decrease in total NPR-C protein is suggested to be dependent on reduction of de novo NPR-C synthesis. PMA-induced transcriptional and post-translational down-regulation of NPR-C was effectively reversible in the presence of the protein kinase C inhibitor GF109203X. These findings demonstrate that protein kinase C activation down-regulated NPR-C expression through transcriptional and post-translational pathways and that immediate functional receptor loss was mediated via a post-translational mechanism, such as enhanced receptor internalization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/Guanylate Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/atrial natriuretic factor receptor C
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
418
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9428739-Atrial Natriuretic Factor,
pubmed-meshheading:9428739-Carcinogens,
pubmed-meshheading:9428739-Down-Regulation,
pubmed-meshheading:9428739-Enzyme Activation,
pubmed-meshheading:9428739-Guanylate Cyclase,
pubmed-meshheading:9428739-HeLa Cells,
pubmed-meshheading:9428739-Humans,
pubmed-meshheading:9428739-Protein Kinase C,
pubmed-meshheading:9428739-Protein Processing, Post-Translational,
pubmed-meshheading:9428739-Receptors, Atrial Natriuretic Factor,
pubmed-meshheading:9428739-Signal Transduction,
pubmed-meshheading:9428739-Tetradecanoylphorbol Acetate,
pubmed-meshheading:9428739-Transcription, Genetic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Protein kinase C activation down-regulates natriuretic peptide receptor C expression via transcriptional and post-translational pathways.
|
pubmed:affiliation |
Lead Generation Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka, Japan.
|
pubmed:publicationType |
Journal Article
|